Vantage logo

Arbutus’s hep B handicap grows

Arbutus Biopharma already looked second best to Arrowhead Pharmaceuticals in the race to develop a functional cure for hepatitis B. New data have made the former’s task…

Medtech

Company Events

Interviews

Vantage Homepage